Trial Profile
A Randomized, Single, Two-Way Crossover Pivotal Study to Assess the Bioequivalence Study of Levetiracetam vs. Keppra Administered Under Fasting Conditions to Healthy Adult Subject.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2009
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy; Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics; Registrational
- 26 Jun 2009 New trial record